These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8640568)

  • 1. Second-generation adenovirus vectors.
    Wang Q; Finer MH
    Nat Med; 1996 Jun; 2(6):714-6. PubMed ID: 8640568
    [No Abstract]   [Full Text] [Related]  

  • 2. An adenovirus type 5 (Ad5) amplicon-based packaging cell line for production of high-capacity helper-independent deltaE1-E2-E3-E4 Ad5 vectors.
    Catalucci D; Sporeno E; Cirillo A; Ciliberto G; Nicosia A; Colloca S
    J Virol; 2005 May; 79(10):6400-9. PubMed ID: 15858023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of an adenovirus vector lacking E1, e2a, E3, and all of E4 except open reading frame 3.
    Gorziglia MI; Lapcevich C; Roy S; Kang Q; Kadan M; Wu V; Pechan P; Kaleko M
    J Virol; 1999 Jul; 73(7):6048-55. PubMed ID: 10364357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A simple method for constructing E1- and E1/E4-deleted recombinant adenoviral vectors.
    Mizuguchi H; Kay MA
    Hum Gene Ther; 1999 Aug; 10(12):2013-7. PubMed ID: 10466635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted.
    Lusky M; Christ M; Rittner K; Dieterle A; Dreyer D; Mourot B; Schultz H; Stoeckel F; Pavirani A; Mehtali M
    J Virol; 1998 Mar; 72(3):2022-32. PubMed ID: 9499056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation and characterization of E1/E2a/E3/E4-deficient adenoviral vectors encoding human factor VIII.
    Andrews JL; Kadan MJ; Gorziglia MI; Kaleko M; Connelly S
    Mol Ther; 2001 Mar; 3(3):329-36. PubMed ID: 11273775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective gene transfer into the liver of non-human primates with E1-deleted, E2A-defective, or E1-E4 deleted recombinant adenoviruses.
    Raper SE; Haskal ZJ; Ye X; Pugh C; Furth EE; Gao GP; Wilson JM
    Hum Gene Ther; 1998 Mar; 9(5):671-9. PubMed ID: 9551615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced toxicity, attenuated immunogenicity and efficient mediation of human p53 gene expression in vivo by an adenovirus vector with deleted E1-E3 and inactivated E4 by GAL4-TATA promoter replacement.
    Ji L; Bouvet M; Price RE; Roth JA; Fang B
    Gene Ther; 1999 Mar; 6(3):393-402. PubMed ID: 10435089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new vector system with inducible E2a cell line for production of higher titer and safer adenoviral vectors.
    Zhou H; Beaudet AL
    Virology; 2000 Sep; 275(2):348-57. PubMed ID: 10998335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of CXCR4 gene expression in primary human endothelial cells following infection with E1(-)E4(+) adenovirus gene transfer vectors.
    Ramalingam R; Worgall S; Rafii S; Crystal RG
    Mol Ther; 2000 Oct; 2(4):381-6. PubMed ID: 11020354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent transgene expression in mouse liver following in vivo gene transfer with a delta E1/delta E4 adenovirus vector.
    Wang Q; Greenburg G; Bunch D; Farson D; Finer MH
    Gene Ther; 1997 May; 4(5):393-400. PubMed ID: 9274715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of first generation E1E3-deleted and second generation E1E3E4-deleted/modified adenovirus vectors on human endothelial cell death.
    Jornot L; Petersen H; Lusky M; Pavirani A; Moix I; Morris ; Rochat T
    Endothelium; 2001; 8(3):167-79. PubMed ID: 11824470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a complementing cell line and a system for construction of adenovirus vectors with E1 and E2a deleted.
    Zhou H; O'Neal W; Morral N; Beaudet AL
    J Virol; 1996 Oct; 70(10):7030-8. PubMed ID: 8794347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A gene transfer vector-cell line system for complete functional complementation of adenovirus early regions E1 and E4.
    Brough DE; Lizonova A; Hsu C; Kulesa VA; Kovesdi I
    J Virol; 1996 Sep; 70(9):6497-501. PubMed ID: 8709289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infection of endothelium with E1(-)E4(+), but not E1(-)E4(-), adenovirus gene transfer vectors enhances leukocyte adhesion and migration by modulation of ICAM-1, VCAM-1, CD34, and chemokine expression.
    Rafii S; Dias S; Meeus S; Hattori K; Ramachandran R; Feuerback F; Worgall S; Hackett NR; Crystal RG
    Circ Res; 2001 May; 88(9):903-10. PubMed ID: 11348999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of a novel adenovirus vector exhibiting microRNA-mediated suppression of the leaky expression of adenovirus genes].
    Shimizu K; Sakurai F; Tachibana M; Mizuguchi H
    Yakugaku Zasshi; 2012; 132(12):1407-12. PubMed ID: 23208048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production and characterization of improved adenovirus vectors with the E1, E2b, and E3 genes deleted.
    Amalfitano A; Hauser MA; Hu H; Serra D; Begy CR; Chamberlain JS
    J Virol; 1998 Feb; 72(2):926-33. PubMed ID: 9444984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved adenoviral vector for vascular gene therapy : beneficial effects on vascular function and inflammation.
    Qian HS; Channon K; Neplioueva V; Wang Q; Finer M; Tsui L; George SE; McArthur J
    Circ Res; 2001 May; 88(9):911-7. PubMed ID: 11349000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Cre-expressing cell line and an E1/E2a double-deleted virus for preparation of helper-dependent adenovirus vector.
    Zhou H; Zhao T; Pastore L; Nageh M; Zheng W; Rao XM; Beaudet AL
    Mol Ther; 2001 Apr; 3(4):613-22. PubMed ID: 11319924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conditional repression of the E2 transcription unit in E1-E3-deleted adenovirus vectors is correlated with a strong reduction in viral DNA replication and late gene expression in vitro.
    Rittner K; Schultz H; Pavirani A; Mehtali M
    J Virol; 1997 Apr; 71(4):3307-11. PubMed ID: 9060700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.